药师参与门诊对儿童喘息性支气管炎的治疗效果

摘要
图/表
参考文献
相关文章 (0)

全文: PDF (973 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨药师参与门诊对儿童喘息性支气管炎的治疗效果。方法选取2020-01至2021-12在武警江西总队医院就诊的200例喘息性支气管炎患儿,随机分为干预组和对照组,每组100例。干预组通过联合门诊综合干预,严格把控住院指征及抗菌药物使用,选择合适的吸入剂型,进行个体化用药指导,对照组采取常规治疗方法。对比两组患儿喘息缓解时间,肺功能指标第1秒用力呼气量(FEV₁)、用力肺活量(FVC)、第1秒用力呼气量与用力肺活量比值(FEV₁/FVC)及治疗费用。两组患儿随访时间为1年,对比再次发作及再次入院次数。结果治疗后,干预组喘息缓解时间显著短于对照组[(39.90±8.76)h vs. (61.55±11.66)h],FEV₁/FVC改善情况优于对照组[(94.52±1.75)% vs. (85.84±4.73)%],差异均有统计学意义(P<0.05)。干预组与对照组比较,住院率、抗菌药物使用率、治疗费用、1年内再次发作喘息次数及住院次数差异均有统计学意义(P<0.05)。结论通过药师参与门诊的干预,可明显提升儿童喘息性支气管炎的治疗效果,降低复发率,减少治疗费用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	梅昕
	白玫
	彭小丹
	周育宏

关键词 ：药师门诊, 联合门诊, 喘息性支气管炎, 治疗费用, 循证药学

Abstract：Objective To explore the effect of pharmacists participating in outpatient treatment of children with asthmatic bronchitis. Methods Two hundred children patients with asthmatic bronchitis who were recruited from January 2020 to December 2021 from the Jiangxi Provincial Corps Hospital of Chinese People’s Armed Police Force were randomly divided into the intervention group and control group, with 100 cases in each group. The intervention group accepted joint outpatient comprehensive intervention, including strict control of the hospitalization indications and the use of antibiotics, appropriate inhalation dosage forms, and individualized medication guidance. The control group received routine treatment. The wheezing relief time, treatment cost and the pulmonary function of the two groups of children were compared. The pulmonary function indexes included forced expiratory volume in the first second (FEV₁), forced vital capacity (FVC), FEV₁/FVC. The two groups were followed up for one year. Results After treatment, the relief time of wheezing in the intervention group was significantly shorter than that in the control group [(39.90±8.76) vs (61.55±11.66)h, P<0.05], and the improvement of FEV₁/FVC was better than that in the control group (94.52%±1.75% vs 85.84%±4.73%, P<0.05). The hospitalization rate, the use rate of antibiotics, the treatment cost, and the number of wheezes and hospitalizations within one year in the intervention group were significantly better than those in the control group (P<0.05). Conclusions Through the participation of pharmacists in outpatient intervention, the therapeutic effect of asthmatic bronchitis in children can be significantly improved, and the recurrence rate and the treatment cost can both be reduced.

Key words： pharmacist clinic joint outpatient department asthmatic bronchitis treatment cost evidence-based pharmacy

收稿日期: 2022-09-13

R952.1

基金资助:江西省卫健委科技计划项目(202211395)

通讯作者: 彭小丹, E-mail:mitfx1987@sina.com

作者简介: 梅昕, 硕士, 主管药师。

引用本文:

梅昕, 白玫, 彭小丹, 周育宏. 药师参与门诊对儿童喘息性支气管炎的治疗效果[J]. 武警医学, 2023, 34(4): 315-318. MEI Xin, BAI Mei, PENG Xiaodan, ZHOU Yuhong. Effect of pharmacists participating in outpatient treatment of children with asthmatic bronchitis. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(4): 315-318.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2023/V34/I4/315

[1]	国家卫生计生委儿童用药专家委员会. 儿童喘息性疾病合理用药指南[J].中华实用儿科临床杂志,2018,33(19):1460-1472.
[2]	梁改丽,王琰华,王潇健,等. 婴幼儿呼吸道合胞病毒和人鼻病毒感染所致急性下呼吸道感染特征及预后分析[J]. 武警医学, 2022, 33(10): 857-861, 865.
[3]	陈慧中,陈志敏,洪建国,等.儿童常见喘息性疾病抗病原微生物药物合理应用专家共识[J].中国实用儿科杂志,2020,35(12):918-926.
[4]	Jartti T,Korppi M. Rhinovirus-induced bronchiolitis and asthma development[J]. Pediatr Allergy Immunol, 2011, 22(4): 350-355.
[5]	梅昕, 冯锦玲, 刘圣根,等. 药师在儿科联合门诊的作用[J]. 中国药学杂志, 2018, 53(2): 159-162.
[6]	Ralston S L, Lieberthal A S, Meissner H C,et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis[J]. Pediatrics,2014,134:e1474-1502.
[7]	Redding G, Wood R A, Tepas E. Treatment of recurrent virus-induced wheezing in young children[DB/OL]. (2021-4-30)[2022-4-28]. https://www.uptodate.com/contents/treatment-of-recurrent-virus-induced-wheezing-in-young-children.
[8]	Global Initiative for Asthma. global strategy for asthma management and prevention: update 2021[EB/OL].[2021-04-26]. http://www.ginaasthma.org/.
[9]	申昆玲,邓力,李云珠,等. 糖皮质激素雾化吸入疗法在儿科应用的专家共识(2018年修订版)[J]. 临床儿科杂志,2018,36(2):95-107.
[10]	中华医学会儿科学分会临床药理学组.中国儿童咳嗽指南(2021患者版)[J].儿科药学杂志,2021,27(S1):17-22.
[11]	中华医学会儿科学分会临床药理学组.中国儿童咳嗽诊断与治疗临床实践指南(2021版)[J].中华儿科杂志,2021,59(9):720-729.
[12]	中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志,2020,43(12):1023-1048.
[13]	王卫华,李松康,陆亚鹏,等.止喘灵口服液联合沙丁胺醇治疗儿童喘息性支气管炎的临床研究[J].现代药物与临床,2021,36(12):2556-2559.
[14]	刘俊,赵庆贺,许豪杰,等.布地奈德、硫酸特布他林及复方异丙托溴铵三联雾化吸入对喘息性支气管炎患儿炎症反应及肺功能的影响[J].临床医学研究与实践,2021,6(25):43-45.
[15]	梅昕, 肖频, 刘婧,等. 药师综合门诊的探索与初步成效[J]. 医药导报, 2017, 36(6): 698-701.
[16]	吴燕华,张贤,林颖,等.心力衰竭患者医护联合门诊自我管理指导模式的构建与应用[J].护理学杂志,2021,36(22):22-25.
[17]	刘茅茅,杨莉,李志梅,等.医师-药师联合门诊会诊癫痫患者467例[J].脑与神经疾病杂志,2019,27(5):275-279.
[18]	张耀峰,黄静娥,符红波,等.临床药师在医师-药师联合门诊开展药物重整的效果分析[J].中国药业,2022,31(11):121-125.
[19]	National Institute for Health and Care Excellence.Bronchiolitis in children: diagnosis and management[EB/OL]. (2021-08-09)[2023-02-17].https://www.nice.org.uk/guidance/ng9.
[20]	李小玲,何雯,施鹏,等.基于腺病毒肺炎1年随访闭塞性细支气管炎结局的巢式病例对照研究[J].中国循证儿科杂志,2021,16(3):233-236.